SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-19-292454
Filing Date
2019-11-14
Accepted
2019-11-14 17:02:02
Documents
6
Effectiveness Date
2019-11-14

Document Format Files

Seq Description Document Type Size
1 S-3ASR d829912ds3asr.htm S-3ASR 227711
2 EX-4.5 d829912dex45.htm EX-4.5 99571
3 EX-5.1 d829912dex51.htm EX-5.1 5406
4 EX-23.1 d829912dex231.htm EX-23.1 1539
5 GRAPHIC g829912g03n21.jpg GRAPHIC 26555
6 GRAPHIC g829912g1112011527615.jpg GRAPHIC 2495
  Complete submission text file 0001193125-19-292454.txt   375748
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-234698 | Film No.: 191221417
SIC: 2834 Pharmaceutical Preparations